Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 1st Quarter - Report

LYMPHOMA RESEARCH FOUNDATION

via LYMPHOMA RESEARCH FOUNDATION

1st Quarter (Jan 1 - Mar 31) · 2022Posted Apr 15, 2022Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: LYMPHOMA RESEARCH FOUNDATION
Location: New York · United States of America

Registrant

Firm: LYMPHOMA RESEARCH FOUNDATION
Description: Healthcare
Location: NEW YORK, New York, United States of America

Lobbying activities

1 issue

Health Issues
COVID-19: vaccine and monoclonal antibody access for people with cancer
LobbyistsELIZABETH GOSS
TargetedHOUSE OF REPRESENTATIVES · White House Office

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

LYMPHOMA RESEARCH FOUNDATION — Lobbying — Receipts Report